155
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Onychopathy Following Durvalumab Treatment for Extensive-Stage Small-Cell Lung Cancer: A Case Report

, , , , , , & ORCID Icon show all
Pages 2429-2432 | Received 21 Jun 2023, Accepted 25 Aug 2023, Published online: 05 Sep 2023

Figures & data

Figure 1 Changes in the nails of patients after treatment with durvalumab at the same time and at different angles. (A) The ten fingers of both hands. (B) The right thumb. (C) The five fingers of the right hand. (D) The five fingers of the left hand.

Figure 1 Changes in the nails of patients after treatment with durvalumab at the same time and at different angles. (A) The ten fingers of both hands. (B) The right thumb. (C) The five fingers of the right hand. (D) The five fingers of the left hand.

Figure 2 Hematoxylin-eosin (HE) staining (A), periodic acid-Schiff staining (PAS) (B), and periodic acid-silver methenamine (PASM) staining (C) of nail keratinocytes and fibrous connective tissue on the bottom of the fingernails.

Figure 2 Hematoxylin-eosin (HE) staining (A), periodic acid-Schiff staining (PAS) (B), and periodic acid-silver methenamine (PASM) staining (C) of nail keratinocytes and fibrous connective tissue on the bottom of the fingernails.